Literature DB >> 11457673

Pathophysiology of oxidative stress in diabetes mellitus.

B Lipinski1.   

Abstract

Oxidative stress is believed to play an important role, albeit not fully recognized, in the development of vascular complications in diabetes mellitus (DM) particularly type 2. In the majority of studies, attention was focused on lipid oxidation, specifically on that of low-density lipoproteins (LDLs). More recent investigations have revealed that it is not only the lipid but also the apolipoprotein moiety of LDL that becomes oxidatively modified resulting in the formation of insoluble aggregates. Consequently, it has been documented that LDL aggregation was due to the hydroxyl radical-induced dityrosine crosslinking between apo B monomers. In DM patients with atherosclerotic complications, intravascular fibrous deposits were shown to contain, in addition to oxidized LDL, a fibrin-like material (FLM). This material is immunologically identical to fibrin that is normally formed as a result of intravascular activation of the blood coagulation cascade. Although DM patients with vascular disease display increased concentration of plasma fibrinogen (Fbg), the precursor of fibrin, no markers of full blown activation of blood coagulation could be found.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11457673     DOI: 10.1016/s1056-8727(01)00143-x

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  53 in total

1.  Oxidation-induced destabilization of the fibrinogen αC-domain dimer investigated by molecular dynamics simulations.

Authors:  Eric N Pederson; Gianluca Interlandi
Journal:  Proteins       Date:  2019-06-14

2.  Biological properties of butanol extracts from green pine cone of Pinus densiflora.

Authors:  Seoyoun Lee; Won-Baek Kim; So Hae Park; Minji Kim; Doohyun Kim; Jumin Park; Dae Youn Hwang; Heeseob Lee
Journal:  Food Sci Biotechnol       Date:  2018-05-26       Impact factor: 2.391

3.  The role of oxidative stress and antioxidants in diabetic complications.

Authors:  Fatmah A Matough; Siti B Budin; Zariyantey A Hamid; Nasar Alwahaibi; Jamaludin Mohamed
Journal:  Sultan Qaboos Univ Med J       Date:  2012-02-07

Review 4.  Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.

Authors:  Ramesh Kandimalla; Vani Thirumala; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-08-25       Impact factor: 5.187

5.  Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?

Authors:  Wesley E Stites; Jeffrey W Froude
Journal:  Med Hypotheses       Date:  2006-10-24       Impact factor: 1.538

6.  Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol.

Authors:  Manouchehr Nakhjavani; Omid Khalilzadeh; Leila Khajeali; Alireza Esteghamati; Afsaneh Morteza; Arsia Jamali; Sheida Dadkhahipour
Journal:  Lipids       Date:  2010-03-12       Impact factor: 1.880

Review 7.  Endothelium, inflammation, and diabetes.

Authors:  Paresh Dandona
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

8.  Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study.

Authors:  Britt Kveiborg; Thomas S Hermann; Atheline Major-Pedersen; Buris Christiansen; Christian Rask-Madsen; Jakob Raunsø; Lars Køber; Christian Torp-Pedersen; Helena Dominguez
Journal:  Cardiovasc Diabetol       Date:  2010-05-25       Impact factor: 9.951

9.  Role of salivary malondialdehyde in assessment of oxidative stress among diabetics.

Authors:  Komal Smriti; Keerthilatha Muralidhar Pai; Vineetha Ravindranath; Kalyana Chakravarthy Pentapati
Journal:  J Oral Biol Craniofac Res       Date:  2015-12-22

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.